A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study will investigate the safety and efficacy of an investigational drug, PF-04171327
on the signs and symptoms of rheumatoid arthritis in patients that require glucocorticoids
while on background methotrexate. This study will also look at the response of chemical and
biological markers in rheumatoid arthritis patients. Lastly, this study will measure the PK
(amount of drug in the blood) of methotrexate while patients may be taking PF-04171327.